The University of Chicago Header Logo

Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.

Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. N Engl J Med. 2023 May 11; 388(19):1755-1766.

View in: PubMed